 | • レポートコード：QYR2104Z2810 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、単純ヘルペス角膜炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・単純ヘルペス角膜炎治療薬の市場動向 ・企業の競争状況、市場シェア ・単純ヘルペス角膜炎治療薬の種類別市場規模（経口薬、外用薬） ・単純ヘルペス角膜炎治療薬の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・単純ヘルペス角膜炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・単純ヘルペス角膜炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・単純ヘルペス角膜炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・単純ヘルペス角膜炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・単純ヘルペス角膜炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Vectans Pharma、Blistex、Bausch Health、Aurobindo Pharma、Dr. Reddy’s Laboratories、Cipla、Jubilant Cadista、Mylan） ・結論 |
The human herpes simplex keratitis viruses are one of the leading cause of ophthalmic morbidity globally including cytomegalovirus retinitis in AIDS. The market of herpes simplex keratitis treatment is anticipated to grow significantly in the forecast period as the disease outbreak can cause unilateral corneal blindness worldwide. For herpes simplex keratitis treatment market, the basic understanding of how the virus behaves is helpful for manufacturers to understand the efforts that must still be concentrated on making the best use of new antiviral agents and other modes for avoiding inappropriate treatment.
Market Analysis and Insights: Global Herpes Simplex Keratitis Drug Market
The global Herpes Simplex Keratitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herpes Simplex Keratitis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herpes Simplex Keratitis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herpes Simplex Keratitis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herpes Simplex Keratitis Drug market.
Global Herpes Simplex Keratitis Drug Scope and Market Size
Herpes Simplex Keratitis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Simplex Keratitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral Drug
Topical Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Vectans Pharma
Blistex
Bausch Health
Aurobindo Pharma
Dr. Reddy’s Laboratories
Cipla
Jubilant Cadista
Mylan
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Keratitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drug
1.2.3 Topical Drug
1.3 Market by Application
1.3.1 Global Herpes Simplex Keratitis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Keratitis Drug Market Perspective (2016-2027)
2.2 Herpes Simplex Keratitis Drug Growth Trends by Regions
2.2.1 Herpes Simplex Keratitis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Herpes Simplex Keratitis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Herpes Simplex Keratitis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Herpes Simplex Keratitis Drug Industry Dynamic
2.3.1 Herpes Simplex Keratitis Drug Market Trends
2.3.2 Herpes Simplex Keratitis Drug Market Drivers
2.3.3 Herpes Simplex Keratitis Drug Market Challenges
2.3.4 Herpes Simplex Keratitis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Keratitis Drug Players by Revenue
3.1.1 Global Top Herpes Simplex Keratitis Drug Players by Revenue (2016-2021)
3.1.2 Global Herpes Simplex Keratitis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Herpes Simplex Keratitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Herpes Simplex Keratitis Drug Revenue
3.4 Global Herpes Simplex Keratitis Drug Market Concentration Ratio
3.4.1 Global Herpes Simplex Keratitis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Keratitis Drug Revenue in 2020
3.5 Herpes Simplex Keratitis Drug Key Players Head office and Area Served
3.6 Key Players Herpes Simplex Keratitis Drug Product Solution and Service
3.7 Date of Enter into Herpes Simplex Keratitis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Keratitis Drug Breakdown Data by Type
4.1 Global Herpes Simplex Keratitis Drug Historic Market Size by Type (2016-2021)
4.2 Global Herpes Simplex Keratitis Drug Forecasted Market Size by Type (2022-2027)
5 Herpes Simplex Keratitis Drug Breakdown Data by Application
5.1 Global Herpes Simplex Keratitis Drug Historic Market Size by Application (2016-2021)
5.2 Global Herpes Simplex Keratitis Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Herpes Simplex Keratitis Drug Market Size (2016-2027)
6.2 North America Herpes Simplex Keratitis Drug Market Size by Type
6.2.1 North America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021)
6.2.2 North America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027)
6.2.3 North America Herpes Simplex Keratitis Drug Market Size by Type (2016-2027)
6.3 North America Herpes Simplex Keratitis Drug Market Size by Application
6.3.1 North America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021)
6.3.2 North America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027)
6.3.3 North America Herpes Simplex Keratitis Drug Market Size by Application (2016-2027)
6.4 North America Herpes Simplex Keratitis Drug Market Size by Country
6.4.1 North America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021)
6.4.2 North America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Herpes Simplex Keratitis Drug Market Size (2016-2027)
7.2 Europe Herpes Simplex Keratitis Drug Market Size by Type
7.2.1 Europe Herpes Simplex Keratitis Drug Market Size by Type (2016-2021)
7.2.2 Europe Herpes Simplex Keratitis Drug Market Size by Type (2022-2027)
7.2.3 Europe Herpes Simplex Keratitis Drug Market Size by Type (2016-2027)
7.3 Europe Herpes Simplex Keratitis Drug Market Size by Application
7.3.1 Europe Herpes Simplex Keratitis Drug Market Size by Application (2016-2021)
7.3.2 Europe Herpes Simplex Keratitis Drug Market Size by Application (2022-2027)
7.3.3 Europe Herpes Simplex Keratitis Drug Market Size by Application (2016-2027)
7.4 Europe Herpes Simplex Keratitis Drug Market Size by Country
7.4.1 Europe Herpes Simplex Keratitis Drug Market Size by Country (2016-2021)
7.4.2 Europe Herpes Simplex Keratitis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size (2016-2027)
8.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type
8.2.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application
8.3.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region
8.4.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Herpes Simplex Keratitis Drug Market Size (2016-2027)
9.2 Latin America Herpes Simplex Keratitis Drug Market Size by Type
9.2.1 Latin America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Herpes Simplex Keratitis Drug Market Size by Type (2016-2027)
9.3 Latin America Herpes Simplex Keratitis Drug Market Size by Application
9.3.1 Latin America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Herpes Simplex Keratitis Drug Market Size by Application (2016-2027)
9.4 Latin America Herpes Simplex Keratitis Drug Market Size by Country
9.4.1 Latin America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size (2016-2027)
10.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type
10.2.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application
10.3.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country
10.4.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Herpes Simplex Keratitis Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Vectans Pharma
11.2.1 Vectans Pharma Company Details
11.2.2 Vectans Pharma Business Overview
11.2.3 Vectans Pharma Herpes Simplex Keratitis Drug Introduction
11.2.4 Vectans Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.2.5 Vectans Pharma Recent Development
11.3 Blistex
11.3.1 Blistex Company Details
11.3.2 Blistex Business Overview
11.3.3 Blistex Herpes Simplex Keratitis Drug Introduction
11.3.4 Blistex Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.3.5 Blistex Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Details
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Herpes Simplex Keratitis Drug Introduction
11.4.4 Bausch Health Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.4.5 Bausch Health Recent Development
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Details
11.5.2 Aurobindo Pharma Business Overview
11.5.3 Aurobindo Pharma Herpes Simplex Keratitis Drug Introduction
11.5.4 Aurobindo Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.5.5 Aurobindo Pharma Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Details
11.6.2 Dr. Reddy’s Laboratories Business Overview
11.6.3 Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Introduction
11.6.4 Dr. Reddy’s Laboratories Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Cipla
11.7.1 Cipla Company Details
11.7.2 Cipla Business Overview
11.7.3 Cipla Herpes Simplex Keratitis Drug Introduction
11.7.4 Cipla Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.7.5 Cipla Recent Development
11.8 Jubilant Cadista
11.8.1 Jubilant Cadista Company Details
11.8.2 Jubilant Cadista Business Overview
11.8.3 Jubilant Cadista Herpes Simplex Keratitis Drug Introduction
11.8.4 Jubilant Cadista Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.8.5 Jubilant Cadista Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Herpes Simplex Keratitis Drug Introduction
11.9.4 Mylan Revenue in Herpes Simplex Keratitis Drug Business (2016-2021)
11.9.5 Mylan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Herpes Simplex Keratitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drug
Table 3. Key Players of Topical Drug
Table 4. Global Herpes Simplex Keratitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Herpes Simplex Keratitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Herpes Simplex Keratitis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Herpes Simplex Keratitis Drug Market Share by Regions (2016-2021)
Table 8. Global Herpes Simplex Keratitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Herpes Simplex Keratitis Drug Market Share by Regions (2022-2027)
Table 10. Herpes Simplex Keratitis Drug Market Trends
Table 11. Herpes Simplex Keratitis Drug Market Drivers
Table 12. Herpes Simplex Keratitis Drug Market Challenges
Table 13. Herpes Simplex Keratitis Drug Market Restraints
Table 14. Global Herpes Simplex Keratitis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Herpes Simplex Keratitis Drug Market Share by Players (2016-2021)
Table 16. Global Top Herpes Simplex Keratitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Keratitis Drug as of 2020)
Table 17. Ranking of Global Top Herpes Simplex Keratitis Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Herpes Simplex Keratitis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Herpes Simplex Keratitis Drug Product Solution and Service
Table 21. Date of Enter into Herpes Simplex Keratitis Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Herpes Simplex Keratitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Herpes Simplex Keratitis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Herpes Simplex Keratitis Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Herpes Simplex Keratitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Herpes Simplex Keratitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Herpes Simplex Keratitis Drug Product
Table 64. GlaxoSmithKline Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Vectans Pharma Company Details
Table 67. Vectans Pharma Business Overview
Table 68. Vectans Pharma Herpes Simplex Keratitis Drug Product
Table 69. Vectans Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 70. Vectans Pharma Recent Development
Table 71. Blistex Company Details
Table 72. Blistex Business Overview
Table 73. Blistex Herpes Simplex Keratitis Drug Product
Table 74. Blistex Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 75. Blistex Recent Development
Table 76. Bausch Health Company Details
Table 77. Bausch Health Business Overview
Table 78. Bausch Health Herpes Simplex Keratitis Drug Product
Table 79. Bausch Health Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 80. Bausch Health Recent Development
Table 81. Aurobindo Pharma Company Details
Table 82. Aurobindo Pharma Business Overview
Table 83. Aurobindo Pharma Herpes Simplex Keratitis Drug Product
Table 84. Aurobindo Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 85. Aurobindo Pharma Recent Development
Table 86. Dr. Reddy’s Laboratories Company Details
Table 87. Dr. Reddy’s Laboratories Business Overview
Table 88. Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Product
Table 89. Dr. Reddy’s Laboratories Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 90. Dr. Reddy’s Laboratories Recent Development
Table 91. Cipla Company Details
Table 92. Cipla Business Overview
Table 93. Cipla Herpes Simplex Keratitis Drug Product
Table 94. Cipla Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 95. Cipla Recent Development
Table 96. Jubilant Cadista Company Details
Table 97. Jubilant Cadista Business Overview
Table 98. Jubilant Cadista Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 99. Jubilant Cadista Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Herpes Simplex Keratitis Drug Product
Table 103. Mylan Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million)
Table 104. Mylan Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Simplex Keratitis Drug Market Share by Type: 2020 VS 2027
Figure 2. Oral Drug Features
Figure 3. Topical Drug Features
Figure 4. Global Herpes Simplex Keratitis Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Herpes Simplex Keratitis Drug Report Years Considered
Figure 9. Global Herpes Simplex Keratitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Herpes Simplex Keratitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Herpes Simplex Keratitis Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Herpes Simplex Keratitis Drug Market Share by Regions (2022-2027)
Figure 13. Global Herpes Simplex Keratitis Drug Market Share by Players in 2020
Figure 14. Global Top Herpes Simplex Keratitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Keratitis Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Herpes Simplex Keratitis Drug Revenue in 2020
Figure 16. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Herpes Simplex Keratitis Drug Market Share by Type (2016-2027)
Figure 20. North America Herpes Simplex Keratitis Drug Market Share by Application (2016-2027)
Figure 21. North America Herpes Simplex Keratitis Drug Market Share by Country (2016-2027)
Figure 22. United States Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Herpes Simplex Keratitis Drug Market Share by Type (2016-2027)
Figure 26. Europe Herpes Simplex Keratitis Drug Market Share by Application (2016-2027)
Figure 27. Europe Herpes Simplex Keratitis Drug Market Share by Country (2016-2027)
Figure 28. Germany Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Herpes Simplex Keratitis Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Herpes Simplex Keratitis Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Herpes Simplex Keratitis Drug Market Share by Region (2016-2027)
Figure 38. China Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Herpes Simplex Keratitis Drug Market Share by Type (2016-2027)
Figure 46. Latin America Herpes Simplex Keratitis Drug Market Share by Application (2016-2027)
Figure 47. Latin America Herpes Simplex Keratitis Drug Market Share by Country (2016-2027)
Figure 48. Mexico Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Herpes Simplex Keratitis Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Herpes Simplex Keratitis Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Herpes Simplex Keratitis Drug Market Share by Country (2016-2027)
Figure 54. Turkey Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 58. Vectans Pharma Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 59. Blistex Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 60. Bausch Health Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 61. Aurobindo Pharma Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 62. Dr. Reddy’s Laboratories Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 63. Cipla Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 64. Jubilant Cadista Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の眼部帯状ヘルペス治療薬市場規模・現状・予測（2021年-2027年） Herpes Zoster Ophthalmicus is a diseases which activates itself due to the reoccurrence of varicella zoster virus infection. The disease involves eye and damages the eye and its surrounding structures due to inflammation of nerves. Market Analysis and Insights: Global Herpes Zoster Ophthalmicus Drug…- 世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blis…
- 世界の単純ヘルペスウイルス検査市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Testing is the procedure to test if the patient have the Herpes Simplex Virus Market Analysis and Insights: Global Herpes Simplex Virus Testing Market The global Herpes Simplex Virus Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, a…
- 世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…